Whole-tumor perfusion CT in patients with advanced lung adenocarcinoma treated with conventional and antiangiogenetic chemotherapy : Initial experience

Radiology

Volumn 259, Issue 2, 2011, Pages 574-582

  Fraioli, Francesco ^a   Anzidei, Michele ^a   Zaccagna , Fulvio ^a   Mennini, Maria Luisa ^a   Serra, Goffredo ^a   Gori, Bruno ^a   Longo, Flavia ^a   Catalano, Carlo ^a   Passariello, Roberto ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENESIS INHIBITOR; BEVACIZUMAB; CARBOPLATIN; IOMERON 350; PACLITAXEL; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIANGIOGENIC THERAPY; ARTICLE; BLOOD VESSEL PERMEABILITY; BLOOD VOLUME; CANCER CHEMOTHERAPY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FOLLOW UP; HUMAN; INOPERABLE CANCER; LUNG ADENOCARCINOMA; LUNG PERFUSION; MALE; PRIORITY JOURNAL; TREATMENT RESPONSE; TUMOR BLOOD FLOW;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANGIOGENESIS INHIBITORS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CONTRAST MEDIA; FEMALE; HUMANS; IOPAMIDOL; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOVASCULARIZATION, PATHOLOGIC; PROSPECTIVE STUDIES; RADIOGRAPHIC IMAGE INTERPRETATION, COMPUTER-ASSISTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79955002324     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.11100600     Document Type: Article

References (28)

1. Jemal A , Siegel R , Ward E , et al. Cancer statistics, 2008. CA Cancer J Clin 2008 ; 58 (2): 71-96. (Pubitemid 351521864)
2. Schiller JH , Harrington D , Belani CP , et al. Eastern Cooperative Oncology Group. Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer. N Engl J Med 2002 ; 346 (2): 92-98. (Pubitemid 34438899)
3. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1990 ; 82 (1): 4-6. (Pubitemid 20020880)
4. Fontanini G , Vignati S , Boldrini L , et al. Vascular endothelial growth factor is associated with neovascularization and infl uences progression of non-small cell lung carcinoma. Clin Cancer Res 1997 ; 3 (6): 861-865. (Pubitemid 27252933)
5. Scagliotti G , Govindan R. Targeting angiogenesis with multitargeted tyrosine kinase inhibitors in the treatment of non-small cell lung cancer. Oncologist 2010 ; 15 (5): 436-446.
6. Sandler A , Gray R , Perry MC , et al. Paclitaxel-carboplatin alone or with bevacizumab for non-small-cell lung cancer. N Engl J Med 2006 ; 355 (24): 2542-2550. (Pubitemid 44917502)
7. Shepherd FA , Rodrigues Pereira J , Ciuleanu T , et al. Erlotinib in previously treated nonsmall- cell lung cancer. N Engl J Med 2005 ; 353 (2): 123-132. (Pubitemid 41058344)
8. World Health Organization. WHO handbook for reporting results of cancer treatment. Offset publication no. 48. Geneva, Switzerland: World Health Organization, 1979. http://whqlibdoc.who.int/offset/WHO-OFFSET-48.pdf.
9. Therasse P , Arbuck SG , Eisenhauer EA , et al. New guidelines to evaluate the response to treatment in solid tumors: European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000 ; 92 (3): 205-216.
10. Drevs J , Schneider V. The use of vascular biomarkers and imaging studies in the early clinical development of anti-tumour agents targeting angiogenesis. J Intern Med 2006 ; 260 (6): 517-529. (Pubitemid 44772371)
11. Wang J , Wu N , Cham MD , Song Y. Tumor response in patients with advanced nonsmall cell lung cancer: Perfusion CT evaluation of chemotherapy and radiation therapy. AJR Am J Roentgenol 2009 ; 193 (4): 1090-1096.
12. Ng QS , Goh V , Fichte H , et al. Lung cancer perfusion at multi-detector row CT: Reproducibility of whole tumor quantitative measurements. Radiology 2006 ; 239 (2): 547-553.
13. Park MS , Klotz E , Kim MJ , et al. Perfusion CT: Noninvasive surrogate marker for stratification of pancreatic cancer response to concurrent chemo- and radiation therapy. Radiology 2009 ; 250 (1): 110-117.
14. Kiessling F , Boese J , Corvinus C , et al. Perfusion CT in patients with advanced bronchial carcinomas: A novel chance for characterization and treatment monitoring? Eur Radiol 2004 ; 14 (7): 1226-1233. (Pubitemid 38979216)
15. Ng QS , Goh V , Milner J , Padhani AR , Saunders MI , Hoskin PJ. Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: In vivo whole tumor assessment using volumetric perfusion computed tomography. Int J Radiat Oncol Biol Phys 2007 ; 67 (2): 417-424. (Pubitemid 46108337)
16. Eisenhauer EA , Therasse P , Bogaerts J , et al. New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 2009 ; 45 (2): 228-247.
17. Saddi KA , Chefd'hotel C , Cheriet F. Large deformation registration of contrast-enhanced images with volume-preserving constraint. In: Pluim JPW, Reinhardt JM, eds. Proceedings of SPIE: Medical imaging 2007-image processing. Vol 6512. Bellingham, Wash: SPIE-The International Society for Optical Engineering, 2007 ; 651203.
18. Bellomi M , Petralia G , Sonzogni A , Zampino MG , Rocca A. CT perfusion for the monitoring of neoadjuvant chemotherapy and radiation therapy in rectal carcinoma: Initial experience. Radiology 2007 ; 244 (2): 486-493. (Pubitemid 47080881)
19. Sahani DV , Kalva SP , Hamberg LM , et al. Assessing tumor perfusion and treatment response in rectal cancer with multisection CT: Initial observations. Radiology 2005 ; 234 (3): 785-792. (Pubitemid 40250822)
20. Kimura H , Braun RD , Ong ET , et al. Fluctuations in red cell flux in tumor microvessels can lead to transient hypoxia and reoxygenation in tumor parenchyma. Cancer Res 1996 ; 56 (23): 5522-5528. (Pubitemid 27011389)
21. Chaplin DJ , Hill SA. Temporal heterogeneity in microregional erythrocyte flux in experimental solid tumours. Br J Cancer 1995 ; 71 (6): 1210-1213.
22. Hakimé A , Peddi H , Hines-Peralta AU , et al. CT perfusion for determination of pharmacologically mediated blood fl ow changes in an animal tumor model. Radiology 2007 ; 243 (3): 712-719. (Pubitemid 46799424)
23. Li Y , Yang ZG , Chen TW , Chen HJ , Sun JY , Lu YR. Peripheral lung carcinoma: Correlation of angiogenesis and first-pass perfusion parameters of 64-detector row CT. Lung Cancer 2008 ; 61 (1): 44-53. (Pubitemid 351862323)
24. Ng QS , Goh V , Klotz E , et al. Quantitative assessment of lung cancer perfusion using MDCT: Does measurement reproducibility improve with greater tumor volume coverage? AJR Am J Roentgenol 2006 ; 187 (4): 1079-1084. (Pubitemid 44453967)
25. Goh V , Halligan S , Hugill JA , Bartram CI. Quantitative assessment of tissue perfusion using MDCT: Comparison of colorectal cancer and skeletal muscle measurement reproducibility. AJR Am J Roentgenol 2006 ; 187 (1): 164-169. (Pubitemid 46100163)
26. Bisdas S , Surlan-Popovic K , Didanovic V , Vogl TJ. Functional CT of squamous cell carcinoma in the head and neck: Repeatability of tumor and muscle quantitative measurements, inter- and intra-observer agreement. Eur Radiol 2008 ; 18 (10): 2241-2250.
27. Ovali GY , Sakar A , Göktan C , et al. Thorax perfusion CT in non-small cell lung cancer. Comput Med Imaging Graph 2007 ; 31 (8): 686-691. (Pubitemid 47600614)
28. Tognolini A , Schor-Bardach R , Pianykh OS , Wilcox CJ , Raptopoulos V , Goldberg SN. Body tumor CT perfusion protocols: Optimization of acquisition scan parameters in a rat tumor model. Radiology 2009 ; 251 (3): 712-720.